Publication | Closed Access

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2–specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis

Anti-inflammatoryGastrointestinal PharmacologyCyclooxygenase 2–SpecificMedicineChronic Musculoskeletal ConditionOsteoarthritisGastroduodenal MucosaPharmacotherapyRandomized TrialPharmacologyOrthopaedic SurgeryInflammatory Arthritis